Verrica Pharmaceuticals stock drops following another setback for its lead drug candidate

"We remain confident that we have a path forward."
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.